Alnylam Pharmaceuticals | ALNY - Денежные средства и эквиваленты

Биржевая цена
313.33
Изменение за день
12.14 4.03%
Ежемесячно
-5.30%
Ежегодный
22.81%
Q2 прогноз
299.00




Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 9.13B 316M 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Moderna USD 2.6B 1.46B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xencor USD 54.07M 25.78M 2025-12